Your browser doesn't support javascript.
loading
Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation.
Cieniewicz, Brandon; Bhatta, Ankit; Torabi, Damoun; Baichoo, Priya; Saxton, Mike; Arballo, Alexander; Nguyen, Linh; Thomas, Sunil; Kethar, Harini; Kukutla, Phanidhar; Shoaga, Omolola; Yu, Bi; Yang, Zhuo; Fate, Maria; Oliveira, Edson; Ning, Hongxiu; Corey, Lawrence; Corey, Daniel.
Afiliação
  • Cieniewicz B; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Bhatta A; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Torabi D; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Baichoo P; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Saxton M; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Arballo A; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Nguyen L; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Thomas S; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Kethar H; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Kukutla P; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Shoaga O; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Yu B; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Yang Z; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Fate M; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Oliveira E; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Ning H; Cero Therapeutics Inc, South San Francisco, CA 94080, USA.
  • Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Corey D; Cero Therapeutics Inc, South San Francisco, CA 94080, USA. Electronic address: dcorey@cero.bio.
Mol Ther ; 31(7): 2132-2153, 2023 07 05.
Article em En | MEDLINE | ID: mdl-37194236

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mol Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mol Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos